Disopyramide contraindications: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Disopyramide}} {{CMG}}; {{AE}} {{SS}} ==Contraindications== Norpace and Norpace CR are contraindicated in the presence of cardiogenic shock, preexisting seco...")
 
(Redirected page to Disopyramide#Contraindications)
 
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Disopyramide#Contraindications]]
{{Disopyramide}}
{{CMG}}; {{AE}} {{SS}}
 
==Contraindications==
 
Norpace and Norpace CR are contraindicated in the presence of [[cardiogenic shock]], preexisting second- or third-degree AV block (if no pacemaker is present), congenital Q-T prolongation, or known [[hypersensitivity]] to the drug.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = NORPACE (DISOPYRAMIDE PHOSPHATE) CAPSULE, GELATIN COATED [G.D. SEARLE LLC DIVISION OF PFIZER INC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e2aa1642-d262-4520-bc6a-9fd3ad795677 | publisher =  | date =  | accessdate = 3 March 2014 }}</ref>
 
 
 
==References==
{{Reflist}}
 
[[Category:Pyridines]]
[[Category:Sodium channel blockers]]
[[Category:Amides]]
[[Category:Cardiovascular Drugs]]
[[Category:Drugs]]

Latest revision as of 02:56, 22 July 2014